NASDAQ:QNCX | Operating Income | Quince Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$79.78M
2026-03-31-$14.59M
2025-12-31-$19.35M
2025-09-30-$13.43M
2025-06-30-$10.43M
2025-03-31-$14.86M
2024-12-31-$12.01M
2024-09-30-$5.86M
2024-06-30-$28.19M
2024-03-31-$11.22M
2023-12-31-$9.92M
2023-09-30-$6.09M
2023-06-30-$5.58M
2023-03-31-$12.96M
2022-12-31-$6.32M
2022-09-30-$7.62M
2022-06-30-$16.26M
2022-03-31-$21.86M
2021-12-31-$23.54M
2021-09-30-$21.68M
2021-06-30-$21.78M
2021-03-31-$23.31M
2020-12-31-$20.85M
2020-09-30-$21.91M
2020-06-30-$18.27M
2020-03-31-$17.86M
2019-12-31-$12.95M
2019-09-30-$10.57M
2019-06-30-$9.58M
2019-03-31-$6.08M
2018-12-31-$3.84M
2018-09-30-$2.87M
2018-06-30-$2.64M
2018-03-31-$2.76M

Annual Operating Income

DateOperating Income
2025-12-31-$58.07M
2024-12-31-$57.29M
2023-12-31-$34.62M
2022-12-31-$52.02M
2021-12-31-$90.32M
2020-12-31-$78.89M
2019-12-31-$39.17M
2018-12-31-$12.12M